Haplotypic analysis of the MMP-9 gene in relation to coronary artery disease

Angharad R Morgan1, Baiping Zhang, William Tapper

  • 1Human Genetics Division, School of Medicine, University of Southampton, Southampton General Hospital, Tremona Road, Southampton, SO16 6YD, UK.

Journal of Molecular Medicine (Berlin, Germany)
|May 3, 2003
PubMed

Insights

Genetic variations in the matrix metalloproteinase-9 (MMP-9) gene are linked to coronary artery disease risk. Specific MMP-9 gene polymorphisms influence atherosclerosis development and severity, impacting coronary stenosis risk.

Area of Science:

  • Cardiovascular Genetics
  • Molecular Medicine

Background:

  • Atherosclerosis, the primary cause of coronary artery disease, involves matrix metalloproteinase-9 (MMP-9).
  • Genetic variations in the MMP-9 gene may influence atherosclerosis development.

Purpose of the Study:

  • To investigate the association between common MMP-9 gene polymorphisms and the development of atherosclerosis.
  • To determine if MMP-9 genetic variations impact the risk and severity of coronary stenosis.

Main Methods:

  • Analyzed three common MMP-9 polymorphisms (-1562C>T, R+279Q, +6C>T) in 1510 white subjects undergoing coronary angiography.
  • Utilized logistic regression and haplotype analyses to assess the relationship between genotypes, alleles, haplotypes, and coronary stenosis.

Main Results:

  • The -1562C>T polymorphism showed significantly higher frequencies in patients with coronary stenosis.
  • Carrying the -1562T allele was associated with a 1.5-fold increased risk of coronary stenosis.
  • The C-G-C haplotype demonstrated a protective effect, reducing the risk and severity of coronary atherosclerosis.

Conclusions:

  • Genetic variation in the MMP-9 gene significantly influences the development and progression of atherosclerosis.
  • The -1562C>T polymorphism and the C-G-C haplotype are key genetic factors affecting coronary artery disease risk.
  • MMP-9 gene polymorphisms impact both the susceptibility and the extent of coronary stenosis.

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...